-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster III Clinically Relevant Abstract

Symposia: Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Damia Romero-Moya1*, Oskar Marin-Bejar, PhD1*, Maximiliano Distefano2*, Joan Pera1*, Julio Castaño, PhD3*, Jessica Gonzalez, PhD4*, Lili Kotmayer5*, Csaba Bödör, PhD6*, Albert Català, MD, PhD2,7*, Marcin W. Wlodarski, MD, PhD8, Anna Bigas, PhD4,9* and Alessandra Giorgetti, PhD1,10*

1Regenerative Medicine Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet De Llobregat, Spain
2Department of Hematology and Oncology, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Deu, Barcelona, Spain
3Immunotherapy Unit, Banc de Sang i Teixits, Barcelona, Spain
4Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques, CIBERONC, Hospital del Mar, Barcelona, Spain
5HCEMM-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, AL, Hungary
6HCEMM-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary
7Instituto de Salud Carlos III, Biomedical Network Research Centre on Rare Diseases, Madrid, Spain
8Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
9Josep Carreras Research Institute (IJC), Badalona, Spain
10Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Barcelona University, Barcelona, Spain

Suying Liu1,2*, Juliana Ehnot2,3*, Greer Jeffery, BA4*, Seul K Jung, BS5,6*, Theresa N Menna, BS3,6*, Haotian Zheng, BS7*, Louise E. Purton, PhD8 and Peter Kurre, MD6,9

1Perelman School of Medicine, University of Pennsylvannia, Philadelphia, PA
2Comprehensive Bone Marrow Failure Center, Children’s Hospital of Philadelphia, Philadelphia, PA
3Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
4Comprehensive Bone Marrow Failure Center, Department of Pediatrics, Children's hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
5Perelman School of Medicine, University of Pennsylvania,, Philadelphia, PA
6Comprehensive Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia, PA
7Department of Biostatistics, Epidemiology and informatics, University of Pennsylvania, Philadelphia, PA
8Stem Cell Regulation Unit, St Vincent's Institute of Medical Research, Melbourne, Australia
9Perelman School Medicine, University of Pennsylvania, Philadelphia, PA

Willian R. Gomes, MSc1*, Vinicius S. Carvalho, MsC2*, Bárbara A. Santana, PhD3*, Edson Z. Martinez, PhD4*, Leandra Z. Ramalho, MD, PhD5*, Antonio Condino-Neto, MD, PhD6* and Rodrigo T. Calado, MD, PhD7

1Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeirão Preto School of Medicine, University of São Paulo, RIBEIRAO PRETO, AL, Brazil
2Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil
3Department of Medical Imaging, Hematology, and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
4Department of Social Medicine, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirao Preto, Brazil
5Department of Pathology and Forensic Medicine, Ribeirão Preto School of Medicine, University of São Paulo, Ribeirao Preto, Brazil
6Institute of Biomedical Sciences - University of Sao Paulo, Sao Paulo, SP, BRA
7Department of Medical Imaging, Hematology and Clinical Oncology, Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil

Mayuresh Anant Sarangdhar1,2*, Martina Stillinovic, PhD1,2*, Nicola Daniele Andina, MD, PhD1,2,3*, Aubry Tardivel1*, Anne Angelillo-Scherrer, MD-PhD1,2 and Ramanjaneyulu Allam, PhD1,2*

1Department for BioMedical Research, University of Bern, Bern, Switzerland
2Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, Bern, Switzerland
3Department of Biomedicine, University Hospital Basel, Basel, Switzerland

Alejandro Ferrer, PhD1, Rekha Mudappathi2*, Terra L. Lasho, PhD1, Ryan M. Carr, MD, PhD1, Jenna A. Fernandez, PhD1*, Christy Finke, BS1*, Naseema Gangat, MBBS1, Roshini S. Abraham, PhD3, Moritz Binder, MD, MPH1, Abhishek A. Mangaonkar, MBBS1, Junwen Wang, PhD2* and Mrinal M. M. Patnaik, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Mayo Clinic, Scottsdale, AZ
3Nationwide Childrens Hospital, Columbus, OH

Sunisa Kongkiatkamon, MD1*, Chupong Ittiwut2*, Thanawat Rattanathammethee, MD3*, Wanna Chetruengchai2*, Kitsada Wudhikarn4*, Sirorat Kobbuaklee5*, Amornchai Suksusut6*, Pimjai Niparuck, MD7*, Noppacharn Uaprasert, MB, BCH8*, Suporn Chuncharunee, MD7, Udomsak Bunworasate, MD6*, Kanya Suphapeetiporn2*, Ponlapat Rojnuckarin, MD, PhD5 and Chantana Polprasert, MD5*

1Chulalongkorn University and King Chulalongkorn Memorial Hospital, Department of Medicine, Faculty of Medicine, Bangkok, Thailand
2Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Center of Excellence for Medical Genomics,Medical Genomics Cluster, Bangkok, Thailand
3Division of Hematology, Department of Internal Medicine, Chiang Mai University, Chiangmai, THA
4Blood and Marrow Transplantation Program, Chulalongkorn University, Bangkok, Thailand
5Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand
6Division of Hematology, Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
7Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
8Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand

Anna Maierhofer, PhD1*, Lucy C. Fox, MBBS2, Stephan Hutter, PhD1*, Constance Baer, PhD1, Ella Thompson, PhD, BSc2,3*, Tamia Nguyen2*, Nicole Den Elzen, PhD2*, Robin J Filshie, MBChB, PhD, FRACP, FRCPA4, Ing S Tiong, FRACP, FRCPA, MPhil5, Niroshan Nadarajah1*, Manja Meggendorfer, PhD1, Wolfgang Kern, MD1, Claudia Haferlach, MD1, Torsten Haferlach, MD1 and Piers Blombery, MBBS2,3,6

1MLL Munich Leukemia Laboratory, Munich, Germany
2Peter MacCallum Cancer Centre, Melbourne, Australia
3University of Melbourne, Melbourne, Australia
4Department of Hematology, St. Vincent's Hospital Melbourne, Melbourne, VIC, Australia
5Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne, VIC, Australia
6Torsten Haferlach Leukaemiediagnostik Stiftung, Munich, Germany

Felicia Andresen, MD1,2, Martina Sukova, MD3*, Jan Stary, MD4*, Barbara De Moerloose, MD5*, Jutte Van Der Werff Ten Bosch, MD, PhD6*, Michael Dworzak, MD, PhD7,8*, Markus G Seidel, MD9*, Sophia Polychronopoulou, MD, PhD10*, Rita Beier, MD11*, Christian P. Kratz, MD11, Michaela Nathrath, MD, PhD12*, Michael C. Frühwald, MD, PhD13*, Gudrun Göhring, MD14*, Anke K. Bergmann, MD15*, Christina Mayerhofer, MD16,17*, Natalia Rotari, MD16*, Dirk Lebrecht, PhD1*, Senthilkumar Ramamoorthy, PhD16,18*, Ayami Yoshimi, MD, PhD16*, Brigitte Strahm, MD19*, Marcin W. Wlodarski, MD, PhD20,21, Charlotte M. Niemeyer1,22 and Miriam Erlacher, MD, PhD1,22*

1Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany
2Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA
3Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
4Dept. of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
5Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium
6Department of Pediatric Hematology-Oncology, University Hospital Brussel, Brussels, Belgium
7Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria
8Department of Pediatrics, St. Anna Children's Hospital and Cancer Research Institute, Medical University of Vienna, Vienna, Austria
9Division of Pediatric Hematology-Oncology, Medical University Graz, Department of Pediatrics and Adolescent Medicine, Graz, Austria
10Department of Pediatric Hematology-Oncology (T.A.O.), Aghia Sophia Children's Hospital, Athens, Greece
11Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany
12Department of Pediatric Hematology and Oncology, Klinikum Kassel, Kassel, Germany
13Pediatrics and Adolescent Medicine, Department of Pediatric Hematology and Oncology, University Medical Center Augsburg, Augsburg, Germany
14Department of Human Genetics, Medical School Hannover, Hannover, Germany
15Department of Human Genetics, Hannover Medical School (MHH), Hannover, Germany
16Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Faculty of Medicine, University of Freiburg, Freiburg, Germany
17Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, Cambridge, MA
18Institute of Medical Bioinformatics and Systems Medicine, Faculty of Medicine, University of Freiburg, Freiburg, Germany
19Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
20University of Freiburg, Freiburg, Germany
21St. Jude Children's Research Hospital, Memphis, TN
22partner site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany

*signifies non-member of ASH